Hannah is Co-Founder and COO at Prima Mente, an AI biology company focused on the brain; to understand it at a molecular level, protect it from neurological disease, and enhance it in health.
She leads across people, product, partnerships and operations, with a track record of building and scaling early-stage biotech companies, having been employee number 1, 3, 12 and 70. Her work has consistently centred on developing products that translate biological insight into real-world applications, from precision medicine to clinical trials.
Hannah holds a PhD from Queen Mary University of London, where she studied the link between diabetes and bowel cancer, and a degree in pharmacology from University of Bath. She also represented England in netball.